Published in Vaccine Weekly, July 11th, 2007
"The gp140(R2) immunogen induced antibodies that achieved 50% neutralization of 48/48, and 80%...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.